Information Collection

Requirements for Submission of Special Drug Experience Reports More Frequently - Form FDA 2301

IC 191899 under ICR 201001-0910-012 · OMB 0910-0284.

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0284 can be found here:

Documents and Forms

Documents and forms in this information collection
Document Name	Document Type
Form 2301 Transmittal of Periodic Reports and Promotional Material Requirements for Submission of Special Drug Experience Reports More Frequently - Form FDA 2301	Form and Instruction
2301 Transmittal of Periodic Reports and Promotional Material Form FDA 2301.pdf	Form and Instruction

IC Title:

Requirements for Submission of Special Drug Experience Reports More Frequently - Form FDA 2301

Agency IC Tracking Number:

Is this a Common Form?

IC Status: New

Obligation to Respond: Required to Obtain or Retain Benefits

CFR Citation: 21 CFR 514.80 (b)(5)(i)

Information Collection Instruments:

table that charts list of instruments
Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form and Instruction	2301				Yes	Yes	Fillable Printable

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records

Title:

FR Citation:

Number of Respondents: 84

Number of Respondents for Small Entity: 0

Affected Public: Private Sector

Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 0 %

table that charts list of burden
	Requested	Program Change Due to Agency Discretion
Annual Number of Responses for this IC	2,604	2,604
Annual IC Time Burden (Hours)	52	52
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

table that charts IC Documents
Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

Something went wrong when downloading this file. If you have any questions, please send an email to [email protected].